<code id='590B8CBDDC'></code><style id='590B8CBDDC'></style>
    • <acronym id='590B8CBDDC'></acronym>
      <center id='590B8CBDDC'><center id='590B8CBDDC'><tfoot id='590B8CBDDC'></tfoot></center><abbr id='590B8CBDDC'><dir id='590B8CBDDC'><tfoot id='590B8CBDDC'></tfoot><noframes id='590B8CBDDC'>

    • <optgroup id='590B8CBDDC'><strike id='590B8CBDDC'><sup id='590B8CBDDC'></sup></strike><code id='590B8CBDDC'></code></optgroup>
        1. <b id='590B8CBDDC'><label id='590B8CBDDC'><select id='590B8CBDDC'><dt id='590B8CBDDC'><span id='590B8CBDDC'></span></dt></select></label></b><u id='590B8CBDDC'></u>
          <i id='590B8CBDDC'><strike id='590B8CBDDC'><tt id='590B8CBDDC'><pre id='590B8CBDDC'></pre></tt></strike></i>

          hotspot

          hotspot

          author:fashion    Page View:2358
          Aerial photograph of Austin, Texas
          Austin, Texas has become the grounds for dueling powerful interests fighting over health care services for poor patients. Brandon Bell/Getty Images

          AUSTIN, Texas — The partnership between one of the nation’s largest Catholic health systems and a local government agency focused on caring for poor patients was supposed to be mutually beneficial for everyone involved. But it didn’t quite turn out that way.

          The alliance in theory meant that Travis County, home to the growing metro area of Austin, could provide more care to low-income patients cheaper than other big cities in the state. And Ascension, a not-for-profit behemoth, would get to own a brand-new teaching hospital and work with an elite new medical school at the University of Texas at Austin.

          advertisement

          But two decades after the agency and Ascension first came together in the name of providing care for poor patients, their relationship has almost completely unraveled.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          CRISPR pioneers react to Casgevy, first gene
          CRISPR pioneers react to Casgevy, first gene

          CRISPRpioneersJenniferDoudnaandFengZhangIllustration:STAT;Photos:AP,GettyTherevolutionstartedinsilen

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Can sheer will power keep patients alive in their dying hours?

          ArmellaLeungforSTATMarjorieSeverancehadlived91years,fivemonths,andtwoweekswhen,ifyoubelievesuchthing